Theralase Technologies Inc.

TSXV Exchange | Apr 9, 2020, 8:10 PM EDT | Real-time price

TLT $ 0.195 RT
-0.015 (-7.1429%)
Day Low: 0.19
Day High: 0.21
Detailed Quote
Open: 0.20
High: 0.21
Beta: 1.469
Shares Out.: 204,275,375
Total Shares (All Classes)2: 204,275,375
Prev. Close: 0.21
Low: 0.19
VWAP: 0.1954
Escrow Shares: 0
Market Cap (All Classes)2*: 39,833,698
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 204,275,375
EPS: -0.03
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 2.438
Market Cap1: 39,833,698
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Theralase Technologies Inc is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers. Founded in 1994, the company's operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells... More

News Headlines for Theralase Technologies Inc.
Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links

Note: as part of an update to TMX Money, this link will be removed on June 30, 2020. Users wishing to access InfoTSXV can continue to do so directly

News Headlines for Theralase Technologies Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.